Over the past decade, there has been growing interest in the development of therapies and other consumer products derived from hemp extracts. Minnesota regulatory agencies are committed to protecting the health of the public while also taking steps to improve the efficiency of regulations for the lawful marketing of appropriate cannabis and cannabis-derived products.
Misleading and false claims associated with hemp extract products may lead consumers to put off getting important medical care, such as a proper diagnosis, treatment, and supportive care. For that reason, it is important to talk to your doctor about the best way to treat diseases or conditions with existing, approved treatment options.
Unlike drug products approved by the FDA, unapproved cannabis extracts have not been subject to FDA review, and there has been no evaluation regarding whether they are safe and effective to treat a particular disease, what the proper dosage is, how they could interact with other drugs or foods, or whether they have dangerous side effects or other safety concerns.
The FDA is working to answer questions about the science, safety, and quality of products containing cannabis and cannabis-derived compounds. More information can be found in their document "What You Need to Know (And What We're Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD".
